Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BRS Ventures is a diversified business conglomerate headquartered in Abu Dhabi, UAE, with a significant presence in the healthcare and pharmaceutical sectors. Founded by Dr. B.R. Shetty, the group operates Neopharma, a major pharmaceutical manufacturer that produces a wide range of generic medications and provides contract manufacturing services for global pharma companies. The company's healthcare division historically included a controlling stake in NMC Health, though that entity has since undergone independent restructuring. BRS Ventures also maintains interests in financial services, education, and hospitality across the Middle East and India. Despite facing substantial financial restructuring challenges in recent years, the group remains a key player in the regional life sciences landscape through its manufacturing and service delivery arms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BRS Ventures.